…m disruption (CRD) is an emerging environmental risk factor for Crohn’s disease (CD), but its pathogenic interplay with gut microbiota and host…
crohn’s disease
This disease is selected. Its supporting articles are shown below.
Articles mentioning crohn’s disease
172 articles · page 7 of 15…eral neuropathy (TiPN) often necessitates therapy withdrawal in Crohn’s disease (CD) management, and effective preventive or therapeutic measur…
…e enrolled, including 158 with Crohn’s disease (CD) and 66 with ulcerative colitis (UC) ( IDDF2026-ABS-0543 Figure 1). 89.7% of patients had faile…
… of BP and mucosal eosinophilia (ME) (BP+ME) in differentiating ulcerative colitis (UC), Crohn’s disease (CD) and GITB using endoscopic mucosal bi…
….9). 37 (55.2%) patients had Crohn’s disease and 30 (44.8%) had ulcerative colitis. 48 (71.6%) were commenced on upadacitinib and 19 (28.4%) on fi…
…as irritable bowel syndrome. New pathways for the management of Functional Bowel Disease have been agreed across Lincolnshire. They include direct acces…
…llow-up of 7 years (4-12), 77 patients (17.5%) developed CRN: 3 CRC, 5 HGD, 40 hrLGD, 25 lrLGD, 4 IND. Patients with high- and low-…
…ry condition of the gut leading to increased risk of developing colorectal cancer (CRC). IBD-induced CRC, termed colitis-associated cancer (CAC),…
…nit inhibitor, is highly efficacious in participants (pts) with Crohn’s disease (CD). Phase 3 studies (GALAXI 2, GALAXI 3, and GRAVITI) showed …
… a measure of CD activity, and the efficacy of SC guselkumab in CD.…
…or risankizumab (RZB) in patients (pts) with moderate to severe Crohn’s disease (CD) and prior anti-TNF failure. Here, we evaluated the durabil…
…terns that do not align with the conventional classification of ulcerative colitis (UC), Crohn’s disease (CD), or IBD unclassified (IBDu). We aime…